Cargando…

Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism

Melanoma cells are resistant to most anticancer chemotherapeutics. Despite poor response rates and short-term efficacy, chemotherapy remains the main approach to treating this cancer. The underlying mechanisms of the intrinsic chemoresistance of melanoma remain unclear, but elucidating these mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karwaciak, Iwona, Sałkowska, Anna, Karaś, Kaja, Dastych, Jarosław, Ratajewski, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126047/ https://www.ncbi.nlm.nih.gov/pubmed/34068624 http://dx.doi.org/10.3390/ijms22095034

Ejemplares similares

Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages—Potential Implications for Cytokine Storm Syndrome
por: Karwaciak, Iwona, et al.
Publicado: (2021)

SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors
por: Sałkowska, Anna, et al.
Publicado: (2020)

SIRT2 Contributes to the Resistance of Melanoma Cells to the Multikinase Inhibitor Dasatinib
por: Karwaciak, Iwona, et al.
Publicado: (2019)

The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes
por: Karwaciak, Iwona, et al.
Publicado: (2022)

Identification of Novel Molecular Markers of Human Th17 Cells
por: Sałkowska, Anna, et al.
Publicado: (2020)

Identification of Corosolic and Oleanolic Acids as Molecules Antagonizing the Human RORγT Nuclear Receptor Using the Calculated Fingerprints of the Molecular Similarity
por: Pastwińska, Joanna, et al.
Publicado: (2022)

Functional Analysis of the rs774872314, rs116171003, rs200231898 and rs201107751 Polymorphisms in the Human RORγT Gene Promoter Region
por: Ratajewski, Marcin, et al.
Publicado: (2017)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

Epigenetic regulation of CD34 and HIF1A expression during the differentiation of human mast cells
por: Walczak-Drzewiecka, Aurelia, et al.
Publicado: (2013)

The application of machine learning methods to the prediction of novel ligands for RORγ/RORγT receptors
por: Bachorz, Rafał A., et al.
Publicado: (2023)

Hypoxia regulates human mast cell adhesion to fibronectin via the PI3K/AKT signaling pathway
por: Pastwińska, Joanna, et al.
Publicado: (2020)

Hypoxia modulates human mast cell adhesion to hyaluronic acid
por: Pastwińska, Joanna, et al.
Publicado: (2021)

Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells
por: Niemira, Magdalena, et al.
Publicado: (2020)

Recombinant immunotoxin targeting GPC3 is cytotoxic to H446 small cell lung cancer cells
por: Rodakowska, Ewelina, et al.
Publicado: (2021)

Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus
por: Borowiec, Marta, et al.
Publicado: (2016)

ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2020)

Hymenialdisine is Cytotoxic Against Cisplatin-Sensitive but Not Against Cisplatin-Resistant Cell Lines
por: Abdullah, Nada, et al.
Publicado: (2021)

Substrate-Dependent Sensitivity of SIRT1 to Nicotinamide Inhibition
por: Rymarchyk, Stacia, et al.
Publicado: (2021)

Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib
por: Eggermont, Carolien, et al.
Publicado: (2023)

Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin
por: Skripova, Vera, et al.
Publicado: (2022)

Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
por: Acklin, Scarlett, et al.
Publicado: (2022)

RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)
por: Sirinian, Chaido, et al.
Publicado: (2021)

EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines
por: Hiraishi, Yukihiro, et al.
Publicado: (2008)

TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB
por: Xing, Ji, et al.
Publicado: (2022)

Daphnetin Attenuated Cisplatin-Induced Acute Nephrotoxicity With Enhancing Antitumor Activity of Cisplatin by Upregulating SIRT1/SIRT6-Nrf2 Pathway
por: Fan, Xiaoye, et al.
Publicado: (2020)

Absence of Sirt3 aggravates cisplatin nephrotoxicity via enhanced renal tubular apoptosis and inflammation
por: Kim, Dal, et al.
Publicado: (2018)

Exosomes derived from gefitinib-treated EGFR-mutant lung cancer cells alter cisplatin sensitivity via up-regulating autophagy
por: Li, Xiao-Qiu, et al.
Publicado: (2016)

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma
por: Willmes, Christoph, et al.
Publicado: (2016)

Isoorientin Attenuates Cisplatin-Induced Nephrotoxicity Through the Inhibition of Oxidative Stress and Apoptosis via Activating the SIRT1/SIRT6/Nrf-2 Pathway
por: Fan, Xiaoye, et al.
Publicado: (2020)

The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin
por: Wang, Xi‐wen, et al.
Publicado: (2021)

Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury via SIRT6-Mediated Autophagy Activation
por: Li, Zhen, et al.
Publicado: (2022)

TLR2 activation induces antioxidant defence in human monocyte-macrophage cell line models
por: Karwaciak, Iwona, et al.
Publicado: (2017)

Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells
por: Li, Amin, et al.
Publicado: (2020)

Urtica dioica Leaf Infusion Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Cisplatin Treatment
por: Nafeh, Guy, et al.
Publicado: (2023)

Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3β axis
por: Huang, Lin, et al.
Publicado: (2021)

Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019)

Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin
por: Campagna, Roberto, et al.
Publicado: (2020)

Pioglitazone alleviates cisplatin nephrotoxicity by suppressing mitochondria‐mediated apoptosis via SIRT1/p53 signalling
por: Zhang, Jiong, et al.
Publicado: (2020)

Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab
por: Cho, Jeonghee, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_alvbqdggesgi5lm4u3lsu4sb18